Peter Buhl Jensen
Chief Executive Officer at CHOSA ONCOLOGY AB
Network origin in Peter Buhl Jensen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Copenhagen
36
| College/University | Other Consumer Services | 36 |
| Extinct | Pharmaceuticals: Major | 17 | |
12
| Public Company | Biotechnology | 12 |
Allarity Therapeutics A/S
 Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark.
9
| Private Company | Pharmaceuticals: Major | 9 |
Allarity Therapeutics Europe ApS
 Allarity Therapeutics Europe ApS Pharmaceuticals: MajorHealth Technology Allarity Therapeutics Europe ApS operates as a pharmaceutical company that provides oncology products. The firm engages in diagnostics and drug development. The company was founded by Steen Meier Knudsen on August 1, 2012 and is headquartered in Hørsholm, Denmark.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Symbion A/S
 Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark.
7
| Subsidiary | General Government | 7 |
| Public Company | Miscellaneous Commercial Services | 6 | |
Medical Prognosis Institute, Inc.
2
| Subsidiary | 2 | |
Cobis A/S
 Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Symbion Fonden
1
| Private Company | 1 | |
Buhl Krone Holding ApS
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Buhl Jensen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TDC A/S | Major Telecommunications | Director/Board Member Corporate Officer/Principal | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Chairman | |
| ABLIVA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
The Carlsbergfondet Foundation
 The Carlsbergfondet Foundation Financial ConglomeratesFinance Carlsbergfondet Foundation engages in the financing and promotion of art and art sciences. The company was founded by J. C. Jacobsen in 1876 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Chairman Corporate Officer/Principal Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Karolinska Institutet | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Uppsala | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| University of Aarhus | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Technical University of Denmark | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Doctorate Degree | |
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Drugstore Chains | Chairman Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Lund | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Corporate Officer/Principal Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Camurus Lipid Research Foundation | Investment Trusts/Mutual Funds | Director/Board Member Chairman | |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Faculty of Engineering, Lund University | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Corporate Officer/Principal Founder | |
| Danish National Research Foundation | Corporate Officer/Principal Founder | ||
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Corporate Officer/Principal | |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| EVOLVA HOLDING SA | Food: Specialty/Candy | Director/Board Member Founder | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
DHI Group A/S
 DHI Group A/S Packaged SoftwareTechnology Services DHI Group A/S is a Danish company that provides solutions to water challenges. The private company is based in Denmark, specifically in Hørsholm, and has subsidiaries in Singapore, the United States, Australia, and Czechia. The company's expertise includes saving water, sharing it fairly, improving its quality, quantifying its impact, and managing its flow. The company offers access to real-time data and emerging technologies to unlock solutions to water challenges. | Packaged Software | Chairman Chairman | |
| Copenhagen University Hospital | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member | |
Danish Cancer Society
 Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer. | Miscellaneous Commercial Services | Corporate Officer/Principal President | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| XINTELA AB | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| PHARMIVA AB (PUBL) | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Oncology Venture US, Inc.
 Oncology Venture US, Inc. Miscellaneous Commercial ServicesCommercial Services Oncology Venture US, Inc. develops therapies for cancer treatment. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
| 2CUREX AB | Medical Specialties | Founder Director/Board Member | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Founder | |
| ALLARITY THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer Founder |
Statistics
International
| Denmark | 32 |
| Sweden | 13 |
| United States | 5 |
| France | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Miscellaneous | 4 |
Operational
| Director/Board Member | 438 |
| Corporate Officer/Principal | 215 |
| Chairman | 159 |
| Chief Executive Officer | 80 |
| Independent Dir/Board Member | 75 |
Most connected contacts
- Stock Market
- Insiders
- Peter Buhl Jensen
- Company connections
